Clinical Trial Update: Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating NP137 in combination with mFOLFIRINOX for locally advanced pancreatic ductal adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• NP137
• mFOLFIRINOX

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: COMPLETED